Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

MedPlus Health Services' subsidiary Optival Health Solutions has received eight drug license suspension orders from drug control authorities across Karnataka, Telangana, and Maharashtra. The suspensions range from one day to fifteen days, with the longest being a 15-day suspension for the Trimurti Nagar Nagpur store. The total estimated potential revenue loss is approximately Rs. 20.21 lacs across all eight stores. The actions were taken under Rule 65 of the Drugs and Cosmetics Act, 1940 and related Rules, 1945. These appear to be routine regulatory compliance issues at individual store locations rather than a company-wide concern.